ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 138 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $288,910 | -20.0% | 43,250 | +0.4% | 0.00% | -33.3% |
| Q2 2023 | $361,257 | -5.7% | 43,058 | +11.6% | 0.00% | 0.0% |
| Q1 2023 | $383,109 | +38.5% | 38,581 | -3.0% | 0.00% | +50.0% |
| Q4 2022 | $276,702 | +62.8% | 39,756 | +25.0% | 0.00% | 0.0% |
| Q3 2022 | $170,000 | +23.2% | 31,813 | -8.0% | 0.00% | +100.0% |
| Q2 2022 | $138,000 | -47.9% | 34,581 | -42.1% | 0.00% | -66.7% |
| Q1 2022 | $265,000 | -1.5% | 59,706 | -11.2% | 0.00% | 0.0% |
| Q4 2021 | $269,000 | -56.8% | 67,223 | -5.2% | 0.00% | -50.0% |
| Q3 2021 | $623,000 | -27.6% | 70,915 | -6.6% | 0.01% | -25.0% |
| Q2 2021 | $860,000 | +3.1% | 75,903 | +8.1% | 0.01% | 0.0% |
| Q1 2021 | $834,000 | +75.6% | 70,227 | +1.5% | 0.01% | +60.0% |
| Q4 2020 | $475,000 | – | 69,170 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
| Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
| Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
| Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
| Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
| Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
| Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
| Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
| APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |